---
title: "Eli Lilly And Company Limited — Ownership Dossier"
canonical: https://whiteintel.dev/entity/c6292de4-51fd-4fcc-a02b-dd4f7026c8f0
json: https://whiteintel.dev/api/public/dossier/c6292de4-51fd-4fcc-a02b-dd4f7026c8f0
identifier: gb-coh:284385
jurisdiction: GB
risk: Low
source: WhiteIntel corporate-ownership graph
---

# Eli Lilly And Company Limited

**Type:** Company  
**Jurisdiction:** [GB](https://whiteintel.dev/jurisdictions/gb)  
**Identifier:** `gb-coh:284385`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/c6292de4-51fd-4fcc-a02b-dd4f7026c8f0  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/c6292de4-51fd-4fcc-a02b-dd4f7026c8f0  

## Cross-source identity

The same real-world entity, resolved across sources:

- **ELI LILLY AND COMPANY LIMITED** — OpenOwnership · `oo:GB-COH-00284385` — https://whiteintel.dev/entity/874a1b01-1dca-5eb2-a6be-ac3c3bafdaf3

## Ownership & control

### Holdings / subsidiaries

- **ELI LILLY LEASING LIMITED** (beneficial owner) — 87.5% — https://whiteintel.dev/entity/199e2c38-54bc-594d-b812-202d63886b6d
- **LILLY RESEARCH CENTRE LIMITED** (beneficial owner) — 87.5% — https://whiteintel.dev/entity/068e34d1-edca-5fa1-9533-b8f268a54377
- **LILLY INDUSTRIES LIMITED** (beneficial owner) — 87.5% — https://whiteintel.dev/entity/4c31ec83-5aee-5d9c-94a5-29ebfaf73367
- **VERICORE LIMITED** (beneficial owner) — 87.5% — https://whiteintel.dev/entity/cc8f80b6-3623-5121-97c8-7ef51fbbe90e
- **GREENFIELD PHARMACEUTICALS LIMITED** (beneficial owner) — 87.5% — https://whiteintel.dev/entity/4b7dca15-36cc-58f0-98a6-67b51fb97699
- **DISTA PRODUCTS LIMITED** (beneficial owner) — 87.5% — https://whiteintel.dev/entity/aa1a7444-2a13-5d1e-87ca-1c2b9913bad2
- **ELANCO EUROPE LTD.** (beneficial owner) — 87.5% — https://whiteintel.dev/entity/09ab5c12-6225-563f-b14b-6d984e2e3837
- **ELI LILLY HOLDING COMPANY LIMITED** (beneficial owner) — 87.5% — https://whiteintel.dev/entity/b8c28369-2a74-5046-a38d-c9220afbfee6

### UBO chain (walk to the ultimate owner)

A **3-step** ownership/control chain to the ultimate beneficial owner is resolved for this entity. The full cited chain unlocks with a paid API key or a one-off dossier — https://whiteintel.dev/pricing.

## Get the full, resolved dossier (agent-callable)

The above is the free teaser. The resolved **multi-hop UBO chain**, ownership **%**, full **financial history**, itemised **assets** and the hop-by-hop **exposure path** are the paid depth — callable as tools from your agent:

```bash
npx -y @whiteintel/mcp-server   # then: get_dossier · trace_ownership_path · check_offshore_exposure
```

Or unlock a one-off cited dossier for **Eli Lilly And Company Limited** — https://whiteintel.dev/entity/c6292de4-51fd-4fcc-a02b-dd4f7026c8f0 · pricing https://whiteintel.dev/pricing.

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **Eli Lilly And Company Limited**. Human view: https://whiteintel.dev/entity/c6292de4-51fd-4fcc-a02b-dd4f7026c8f0 · Structured JSON: https://whiteintel.dev/api/public/dossier/c6292de4-51fd-4fcc-a02b-dd4f7026c8f0._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._